Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$45.44 - $74.26 $61.3 Million - $100 Million
1,348,150 New
1,348,150 $88.6 Billion
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $56 Million - $110 Million
1,354,187 New
1,354,187 $60.9 Million
Q3 2022

Nov 14, 2022

SELL
$72.36 - $113.1 $60,203 - $94,099
-832 Reduced 0.06%
1,411,029 $102 Million
Q2 2022

Aug 15, 2022

BUY
$87.2 - $114.05 $1.6 Million - $2.1 Million
18,377 Added 1.32%
1,411,861 $151 Million
Q1 2022

May 11, 2022

SELL
$94.19 - $124.49 $1.72 Million - $2.28 Million
-18,275 Reduced 1.29%
1,393,484 $155 Million
Q4 2021

Feb 11, 2022

BUY
$119.57 - $139.07 $979,039 - $1.14 Million
8,188 Added 0.58%
1,411,759 $181 Million
Q3 2021

Nov 12, 2021

SELL
$109.17 - $142.35 $3.73 Million - $4.86 Million
-34,162 Reduced 2.38%
1,403,571 $187 Million
Q2 2021

Aug 11, 2021

SELL
$100.34 - $115.69 $18,261 - $21,055
-182 Reduced 0.01%
1,437,733 $155 Million
Q1 2021

May 13, 2021

BUY
$101.51 - $125.27 $7.66 Million - $9.45 Million
75,448 Added 5.54%
1,437,915 $151 Million
Q4 2020

Feb 09, 2021

BUY
$85.88 - $105.36 $5.56 Million - $6.83 Million
64,787 Added 4.99%
1,362,467 $142 Million
Q3 2020

Nov 12, 2020

SELL
$72.74 - $92.5 $33.7 Million - $42.8 Million
-462,818 Reduced 26.29%
1,297,680 $111 Million
Q2 2020

Aug 12, 2020

BUY
$48.02 - $79.04 $7.03 Million - $11.6 Million
146,459 Added 9.07%
1,760,498 $129 Million
Q1 2020

May 06, 2020

BUY
$36.95 - $62.95 $3.08 Million - $5.25 Million
83,342 Added 5.44%
1,614,039 $83.8 Million
Q4 2019

Feb 14, 2020

BUY
$47.06 - $56.64 $274,783 - $330,720
5,839 Added 0.38%
1,530,697 $86.2 Million
Q3 2019

Nov 07, 2019

SELL
$47.45 - $58.05 $1.36 Million - $1.66 Million
-28,616 Reduced 1.84%
1,524,858 $72.7 Million
Q2 2019

Aug 12, 2019

BUY
$39.26 - $54.21 $1.28 Million - $1.77 Million
32,691 Added 2.15%
1,553,474 $84.2 Million
Q1 2019

May 14, 2019

SELL
$29.84 - $43.92 $392,216 - $577,284
-13,144 Reduced 0.86%
1,520,783 $61.7 Million
Q4 2018

Feb 11, 2019

SELL
$29.95 - $46.34 $3.99 Million - $6.18 Million
-133,305 Reduced 8.0%
1,533,927 $47.8 Million
Q3 2018

Nov 09, 2018

SELL
$40.12 - $45.55 $1.32 Million - $1.5 Million
-32,888 Reduced 1.93%
1,667,232 $0
Q2 2018

Aug 06, 2018

SELL
$38.72 - $42.52 $3.91 Million - $4.3 Million
-101,027 Reduced 5.61%
1,700,120 $71.2 Million
Q1 2018

May 15, 2018

BUY
$39.4 - $47.39 $1.65 Million - $1.98 Million
41,785 Added 2.38%
1,801,147 $74 Million
Q4 2017

Feb 09, 2018

BUY
$37.27 - $43.02 $65.6 Million - $75.7 Million
1,759,362
1,759,362 $72.3 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.